Adivo Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

Adivo General Information

Description

Developer of species-specific therapeutic antibodies designed for companion animals. The company's technology utilizes proprietary phage display antibody libraries and de-novo identification processes to create therapeutic antibodies, oncology drug candidates, inflammatory disease treatments, canine antibody libraries, and feline antibody libraries, providing the veterinary medicine market with targeted treatment options for pets with serious diseases.

Contact Information

Website
www.adivo.vet
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Zeppelinstraße 4
  • 82178 Puchheim
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Zeppelinstraße 4
  • 82178 Puchheim
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adivo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 07-Jun-2023 Completed Generating Revenue
4. Grant 06-Oct-2021 Completed Generating Revenue
3. Early Stage VC 01-Oct-2020 Completed Generating Revenue
2. Grant 30-Apr-2020 $54.3K $2.09M Completed Generating Revenue
1. Seed Round 19-Jul-2018 $2.09M $2.09M Completed Startup
To view Adivo’s complete valuation and funding history, request access »

Adivo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of species-specific therapeutic antibodies designed for companion animals. The company's technology utilizes p
Drug Discovery
Puchheim, Germany
30 As of 2024

Miami Beach, FL
 

Smyrna, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adivo Competitors (10)

One of Adivo’s 10 competitors is SAb Biotherapeutics, a Formerly VC-backed company based in Miami Beach, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SAb Biotherapeutics Formerly VC-backed Miami Beach, FL
GeoVax Labs Corporation Smyrna, GA
Bristol-Myers Squibb Corporation Princeton, NJ
Gilead Formerly VC-backed Foster City, CA
Merck & Co. Corporation Rahway, NJ
You’re viewing 5 of 10 competitors. Get the full list »

Adivo Patents

Adivo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250011431-A1 Anti-canine pd-l1 antibodies Pending 27-Mar-2023
WO-2024200425-A1 Anti-canine pd-l1 antibodies Inactive 27-Mar-2023
US-20250154688-A1 Feline antibody library Pending 18-Feb-2022
WO-2023156625-A1 Feline antibody library Inactive 18-Feb-2022
CA-3167437-A1 Modified fc regions Pending 19-Feb-2020 C07K16/00
To view Adivo’s complete patent history, request access »

Adivo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adivo Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator
High-Tech Gründerfonds Venture Capital Minority
Horizon 2020 Government
MorphoSys Corporation Minority
OCCIDENT () Family Office Minority
To view Adivo’s complete investors history, request access »

Adivo FAQs

  • When was Adivo founded?

    Adivo was founded in 2018.

  • Where is Adivo headquartered?

    Adivo is headquartered in Puchheim, Germany.

  • What is the size of Adivo?

    Adivo has 30 total employees.

  • What industry is Adivo in?

    Adivo’s primary industry is Drug Discovery.

  • Is Adivo a private or public company?

    Adivo is a Private company.

  • What is Adivo’s current revenue?

    The current revenue for Adivo is .

  • How much funding has Adivo raised over time?

    Adivo has raised $2.09M.

  • Who are Adivo’s investors?

    European Innovation Council, High-Tech Gründerfonds, Horizon 2020, MorphoSys, and OCCIDENT () have invested in Adivo.

  • Who are Adivo’s competitors?

    SAb Biotherapeutics, GeoVax Labs, Bristol-Myers Squibb, Gilead, and Merck & Co. are some of the 10 competitors of Adivo.

  • When was Adivo acquired?

    Adivo was acquired on 07-Jun-2023.

  • Who acquired Adivo?

    Adivo was acquired by Zoetis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process